Is Immunoprecise Antibodies Ltd halal to invest in?

As of July 2026, Immunoprecise Antibodies Ltd IPA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Immunoprecise Antibodies Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Immunoprecise Antibodies Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Immunoprecise Antibodies Ltd?

Muslim investors may consider investing in Immunoprecise Antibodies Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Immunoprecise Antibodies Ltd classified as HALAL?

Musaffa determines the Shariah status of Immunoprecise Antibodies Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Immunoprecise Antibodies Ltd updated?

The Shariah compliance status of Immunoprecise Antibodies Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Immunoprecise Antibodies Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Immunoprecise Antibodies Ltd?

You can check the latest Shariah compliance status of Immunoprecise Antibodies Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Immunoprecise Antibodies Ltd IPA

Last Updated: Oct 03, 12:00 AM·BE

IPA Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Immunoprecise Antibodies Ltd is classified as halal.

HALAL

Report Source: 2025 Annual Report

Immunoprecise Antibodies Ltd. Stock Analysis IPA

Germany Health Care Micro Cap Report: 2025 Annual

ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The company is headquartered in Austin, Texas. The company is advancing Bio-Native AI at the intersection of biology and computation. Its LENSai and HYFT platforms enable large-scale reasoning across sequence, structure, function, and scientific literature, powering workflows across drug discovery, diagnostics, vaccine design, and molecular systems biology. The core of its operations encompasses a diverse suite of proprietary technologies that aid in the exploration, discovery, and development of novel drugs and biologics. Integrated within its wet lab infrastructure is a diverse array of in silico technologies. As an end-to-end service provider of antibody discovery and development, its computational methodologies allow the Company to perform detailed and comprehensive evaluations across various stages of biologic discovery and development. The company is involved in antibody characterization studies, which encompass affinity measurements, epitope landscape profiling, and others.

Key Statistics of Immunoprecise Antibodies Ltd (IPA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€1.66€1.79

Today's Open

€1.77

Volume

628.42K

P/E Ratio (TTM)

Market Cap

81.94M

Avg. Volume

1.45M

Dividend Yield

Financial Metrics & Statements of Immunoprecise Antibodies Ltd (IPA)

Super Investors Invested in Immunoprecise Antibodies Ltd (IPA)

FAQ's for Immunoprecise Antibodies Ltd (IPA)

As of July 2026, Immunoprecise Antibodies Ltd IPA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Immunoprecise Antibodies Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Immunoprecise Antibodies Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Immunoprecise Antibodies Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Immunoprecise Antibodies Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Immunoprecise Antibodies Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.